Immunic (NASDAQ:IMUX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Immunic (IMUX) operate in?

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immunic Stock (NASDAQ: IMUX) stock price, news, charts, stock research, profile.

Open	$1.04
Close	$1.11
Volume / Avg.	429.15K / 241.09K
Day Range	1.03 - 1.13
52 Wk Range	0.95 - 3.11
Market Cap	$103.59M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	3.32%
Days to Cover	17.42

Recent News

Immunic And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

What's Going On With Immunic Stock?

Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million.

Erica Kollmann

Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Immunic Inc

Sector

Health Care

Industry

Biotechnology

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral im...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Immunic (IMUX) stock?

You can purchase shares of Immunic (NASDAQ:IMUX) through any online brokerage.

View our list of the best stock brokerages

Who are Immunic (IMUX) competitors?

Other companies in Immunic’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO) and FibroGen (NASDAQ:FGEN).

What is the target price for Immunic (IMUX) stock?

There is no analysis for Immunic.

What is the forecast for Immunic (IMUX) stock?

Immunic has a consensus price target of $21.00.

Current stock price for Immunic (IMUX)?

The stock price for Immunic (NASDAQ: IMUX) is $1.15 last updated June 28, 2024 at 4:28 PM EDT.

Does Immunic (IMUX) pay a dividend?

There are no upcoming dividends for Immunic.

When is Immunic (NASDAQ:IMUX) reporting earnings?

Immunic’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Immunic (IMUX) going to split?

There is no upcoming split for Immunic.

What sector and industry does Immunic (IMUX) operate in?

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Immunic

Immunic (IMUX) Forecast